Jason Aryeh insider trades
Open-market stock purchases and sales by Jason Aryeh, Director at Orchestra BioMed Holdings, Inc, from SEC Form 4 filings since May 29, 2009.
Track record: 100% of 13 scored buys are up 5% or more since purchase, averaging +108%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 23, 2026 | OBIO Orchestra BioMed Holdings, Inc | Bought (not open market) | — |
| Jun 11, 2026 | LGND Ligand Pharmaceuticals Inc | Sold | $1.1M |
| Jun 10, 2026 | LGND Ligand Pharmaceuticals Inc | Sold | $125K |
| Jun 5, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 5, 2026 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 4, 2026 | LFCR Lifecore Biomedical, Inc \de\ | Bought (not open market) | — |
| May 18, 2026 | OBIO Orchestra BioMed Holdings, Inc | Bought | $2.5K |
| May 15, 2026 | OBIO Orchestra BioMed Holdings, Inc | Bought | $35K |
| Dec 8, 2025 | LGND Ligand Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- OBIO Orchestra BioMed Holdings, Inc: 3 buys, last Jun 23, 2026
- LGND Ligand Pharmaceuticals Inc: 27 buys, 32 sales, last Jun 11, 2026
- LFCR Lifecore Biomedical, Inc \de\: other filings, last Jun 4, 2026
- ANEB Anebulo Pharmaceuticals, Inc: other filings, last Apr 4, 2025
- MACK Merrimack Pharmaceuticals Inc: 4 buys, last Jul 16, 2019
- ARLZ Aralez Pharmaceuticals Inc: 1 buy, 3 sales, last May 23, 2017
- NVLN Novelion Therapeutics Inc: 1 buy, last May 15, 2017
- IMMU Immunomedics Inc: other filings, last Jan 8, 2017
- QLTI QLT Inc/bc: 3 buys, 6 sales, last Jun 17, 2016
- MYRX Myrexis, Inc: 23 buys, last Jun 18, 2012
- QLT QLT Inc/bc: other filings, last Jun 16, 2012
- LGNDD Ligand Pharmaceuticals Inc: 1 buy, last Nov 10, 2011